Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Motohiro Itotani is active.

Publication


Featured researches published by Motohiro Itotani.


Current Topics in Medicinal Chemistry | 2007

Screening for Novel Antituberculosis Agents that are Effective Against Multidrug Resistant Tuberculosis

Makoto Matsumoto; Hiroyuki Hashizume; Hidetsugu Tsubouchi; Hirofumi Sasaki; Motohiro Itotani; Hideaki Kuroda; Tatsuo Tomishige; Masanori Kawasaki; Makoto Komatsu

The challenges in preventing and controlling tuberculosis are further complicated by the deadly rise of multi-drug-resistant tuberculosis (MDR-TB). Recognizing the seriousness of the situation, we initiated a program to screen new agents that would satisfy these unmet needs and have a favorable safety profile. Mycobacteria are well known for their lipid-rich properties. In Mycobacterium tuberculosis, mycolic acid in particular has been established the wall component related to the pathogenesis in the host. There are approximately 250 identified genes related to biosynthesis of the lipid turnover that contain InhA, the main target of isoniazid. Thus, the logical approach for developing a chemotherapy agent against tubercle bacilli included screening compounds that could inhibit the biosyntheses of mycolic acid and that had a novel chemical structure to ensure improved efficacy against MDR-TB. Some of the screening systems established for those purposes and some of the candidates are outlined.


Journal of Medicinal Chemistry | 2006

Synthesis and antituberculosis activity of a novel series of optically active 6 -nitro -2,3 -dihydroimidazo [2,1-b ]oxazoles

Hirofumi Sasaki; Yoshikazu Haraguchi; Motohiro Itotani; Hideaki Kuroda; Hiroyuki Hashizume; Tatsuo Tomishige; Masanori Kawasaki; Makoto Matsumoto; Makoto Komatsu; Hidetsugu Tsubouchi


Archive | 2003

2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES

Hidetsugu Tsubouchi; Hirofumi Sasaki; Hideaki Kuroda; Motohiro Itotani; Takeshi Hasegawa; Yoshikazu Haraguchi; Takeshi Kuroda; Takayuki Matsuzaki; Kuninori Tai; Makoto Komatsu; Makoto Matsumoto; Hiroyuki Hashizume; Tatsuo Tomishige; Yuji Seike; Masanori Kawasaki; Takumi Sumida; Shin Miyamura


Archive | 2006

Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders

Hiroshi Yamashita; Hideaki Kuroda; Nobuaki Ito; Shin Miyamura; Kunio Oshima; Jun Matsubara; Haruka Takahashi; Tae Fukushima; Satoshi Shimizu; Kazumi Kondo; Yohji Sakurai; Takeshi Kuroda; Shinichi Taira; Motohiro Itotani; Tatsuyoshi Tanaka


Archive | 2004

2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis

Hidetsugu Tsubouchi; Hirofumi Sasaki; Motohiro Itotani; Yoshikazu Haraguchi; Shin Aza Kitakawamukai Ninokoshi Miyamura; Makoto Matsumoto; Hiroyuki Hashizume; Tatsuo Tomishige; Masanori Kawasaki; Kinue Ohguro; Takumi Sumida; Takeshi Hasegawa; Kazuho Tanaka; Isao Takemura


Archive | 1997

DIHYDROPHENAZINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME AND DRUG FOR TUBERCLE BACILLI AND ATYPICAL ACID-FAST BACILLI

Mikio Kikuchi; Hiroshi Ishikawa; Hideaki Horimoto; Hidetsugu Tsubouchi; Takuya Shitsuta; Hirofumi Sasaki; Motohiro Itotani


Archive | 2017

HETEROBICYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS

Hiroshi Shimizu; Yoshikazu Kawano; Shunpei Ishikawa; Yukitaka Uematsu; Toshio Shinohara; Motohiro Itotani; Yoshikazu Haraguchi; Isao Takemura; Atsunori Kaneshige; Yuya Nakai; Norimitsu Hariguchi; Yohei Hayashi; Makoto Matsumoto


Archive | 2016

COMPUESTOS DE CIANOTRIAZOL

Yohji Sakurai; Motohiro Itotani; Shigekazu Fujita; Takashi Okamoto; Seiji Sato; Satoshi Matsuda; Chiharu Matsumura; Toshio Shinohara; Kuninori Tai; Tae Fukushima; Naohide Kanemoto


Archive | 2012

6,7-DIHYDROIMIDAZO[2,1-B][1,3]OXAZINE BACTERICIDES

Yoshikazu Kawano; Yoshikazu Haraguchi; Hirofumi Sasaki; Yukitaka Uematsu; Hidetsugu Tsubouchi; Hiromi Yata; Hiroshi Shimizu; Kazuho Kohashi; Motohiro Itotani; Kuninori Tai; Isao Takemura; Mikayo Hayashi; Hiroyuki Hashizume; Miki Matsuba; Izuru Nakamura; Xiuhao Chen; Makoto Matsumoto


Archive | 2012

Derivados de 4-piperazin-1-il-4-benzo[b]tiofeno adecuados para el tratamiento de trastornos del SNC

Tae Fukushima; Nobuaki Ito; Motohiro Itotani; Kazumi Kondo; Hideaki Kuroda; Jun Matsubara; Kunio Oshima; Satoshi Shimizu; Hiroshi Yamashita

Collaboration


Dive into the Motohiro Itotani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge